Feb 9 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2017 Dec 31, 2016 Dec 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 198 mln 22 mln 698 mln 0 mln
(+787.2 pct) (-40.6 pct) (+252.2 pct) (-100.0 pct)
Operating loss 983 mln loss 1.34 loss 1.12 loss 811 mln
Recurring loss 988 mln loss 1.30 loss 1.12 loss 809 mln
Net
Net loss 884 mln loss 1.26 loss 1.10 loss 793 mln
EPS loss 103.16 yen loss 155.48 yen loss 123.79 yen loss 89.21 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Medrx.Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T
((Tokyo Headline News Desk +813 6441 1812))